Effect of Home Exercise on Reducing Falls
Launched by CHINESE UNIVERSITY OF HONG KONG · Jul 16, 2018
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
This will be a single-blinded randomized controlled trial. The subjects will be randomly assigned to the LiFE exercise plus home safety assessment group, or the control group by a computer program operated by an independent researcher. This study conforms to the ethical principles of the World Medical Association Declaration of Helsinki.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 60 or older
- • able to ambulate with a Functional Ambulation Category (FAC) score ≥ 3
- • able to walk for ≥ 10 meters
- • history of falls in the past 12 months
- • living in the community
- • without MCI or dementia according to the 5-minute Montreal Cognitive assessment
- • have a moderate fall risk or above as assessed by the Physiological Profile Assessment
- • able to understand Chinese.
- Exclusion Criteria:
- • blindness
- • diagnosis of mental disorders (e.g., severe depression, schizophrenia)
- • any contraindications to exercise (e.g. unstable angina).
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Timothy Kwok, MD
Principal Investigator
The Chinese University of Hong Kong Jockey Club Centre for Osteoporosis Care and Control
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials